Ownership and insider activity for OSR Holdings, Inc. (OSRH): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses.
Price
| Price | $0.12 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-26 | Kim Yeiseok | |||
| 2025-09-17 | Fierz Reto Kaspar | |||
| 2025-02-14 | Cho Joong Myung | |||
| 2025-02-14 | Barberis Alcide | |||
| 2025-02-14 | Kim Sang Harry | |||
| 2025-02-14 | Bang Gihyoun | |||
| 2025-02-14 | Jee Hyuk Joo | |||
| 2025-02-14 | Bellevue Global Life Science Investors LLC | J-Other | 43,000 | |
| 2025-02-14 | Hwang Kuk Hyoun | J-Other | 3,123,970 | |
| 2025-02-14 | Hwang Kuk Hyoun | J-Other | 7,531,634 |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $62653 | $4757 | $2238 | $15419 | $66135 | $1.7M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | $402 | 0 | 0 | $599065 |
| Inventory | 0 | 0 | $858 | 0 | 0 | $196432 |
| Total Current Assets | $62653 | $4757 | $3511 | $22627 | $455398 | $2.8M |
| Property, Plant & Equipment | 0 | 0 | $295 | 0 | 0 | $252167 |
| Goodwill | 0 | 0 | $9642 | 0 | 0 | $24.9M |
| Intangible Assets | 0 | 0 | $82335 | 0 | 0 | $142.5M |
| Total Assets | $322749 | $705087 | $95982 | $36.6M | $2.3M | $171.2M |
| Accounts Payable | 0 | $2847 | $3382 | $1.1M | $2.9M | $7.8M |
| Short-term Debt | $300000 | $400000 | $904 | $72000 | $2.6M | $4.3M |
| Total Current Liabilities | $321561 | $707207 | $4658 | $2.0M | $6.7M | $17.2M |
| Long-term Debt | 0 | 0 | $101 | 0 | 0 | 0 |
| Total Liabilities | $321561 | $707207 | $17216 | $40.5M | $8.8M | $44.2M |
| Retained Earnings | -$23812 | -$27120 | $42 | -$3.9M | -$8.3M | -$37.2M |
| Total Equity | $1188 | -$2120 | $78766 | -$3.9M | -$6.5M | $77.6M |
| Total Debt | $300000 | $400000 | $1240 | $72000 | $2.6M | $4.4M |
| Net Debt | $237347 | $395243 | -$998 | $56581 | $2.6M | $2.7M |
| Working Capital | -$258908 | -$702450 | -$1147 | -$2.0M | -$6.3M | -$14.3M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 0.18 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -0.71 |
Profitability
| Return on Equity | -16.47% |
| Return on Invested Capital | -10.61% |
| Return on Assets | -9.08% |
| Gross Margin | -98.82% |
| Operating Margin | -933.75% |
| Net Margin | -836.91% |
Related companies: ATIF · BNIX · BRLI · CETU · EONR · JVSA · RFAC
Explore sector: Healthcare · Biotechnology
More sections of OSRH: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks